Endocrine therapy and risk of cardiovascular disease and mortality in postmenopausal breast cancer survivors
Our findings suggest endocrine therapy use reduces all-cause mortality risk and may not increase CVD risk in postmenopausal women with early-stage hormone receptor-positive BC.
Authors
- Tatjana Kolevska
- Richard Kar-Hang Cheng (ORCID: https://orcid.org/0000-0001-5994-5998)
- Eileen Rillamas‐Sun (ORCID: https://orcid.org/0000-0002-8637-0437)
- Megan Othus (ORCID: https://orcid.org/0000-0001-8176-6371)
- Lawrence H. Kushi (ORCID: https://orcid.org/0000-0001-9136-1175)
- Mai N. Nguyen‐Huynh (ORCID: https://orcid.org/0000-0002-8228-0282)
- Marilyn L. Kwan (ORCID: https://orcid.org/0000-0001-8863-3950)
- Janise M. Roh (ORCID: https://orcid.org/0000-0002-8615-4320)
- Valerie S. Lee
- Cecile A. Laurent (ORCID: https://orcid.org/0000-0001-9332-6971)
- Heather Greenlee (ORCID: https://orcid.org/0000-0003-4148-1405)
- Dawn L. Hershman (ORCID: https://orcid.org/0000-0001-8807-153X)
- Yuhan Huang (ORCID: https://orcid.org/0009-0000-0995-3455)
- Susan R. Heckbert
- Nicholas L. Smith
- Carlos Irribarren
Institutions
- Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA)
- Kaiser Permanente (US)
- Kaiser Permanente Washington Health Research Institute (US)
- University of Washington (US)
- Columbia University Irving Medical Center (US)
- VA Office of Research and Development (US)
- Fred Hutch Cancer Center (US)
- Kaiser Permanente Walnut Creek Medical Center (US)
- Seattle Epidemiologic Information and Research Center (US)
- Kaiser Permanente Vallejo Medical Center (US)
Publication Details
- Journal
- JNCI Journal of the National Cancer Institute
- Published
- 2025-03-11
- DOI
- https://doi.org/10.1093/jnci/djaf063
- Citations
- 4
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 5.55